Your browser doesn't support javascript.
loading
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide.
Negoro, E; Radivoyevitch, T; Polprasert, C; Adema, V; Hosono, N; Makishima, H; Przychodzen, B; Hirsch, C; Clemente, M J; Nazha, A; Santini, V; McGraw, K L; List, A F; Sole, F; Sekeres, M A; Maciejewski, J P.
Afiliación
  • Negoro E; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Radivoyevitch T; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
  • Polprasert C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Adema V; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
  • Hosono N; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Makishima H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Przychodzen B; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hirsch C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Clemente MJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Nazha A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Santini V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • McGraw KL; Hematology Unit, AOU Careggi, University of Florence, Firenze, Italy.
  • List AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Sole F; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Sekeres MA; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Leukemia ; 30(12): 2405-2409, 2016 12.
Article en En | MEDLINE | ID: mdl-27560106
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talidomida / Síndromes Mielodisplásicos / Factores Inmunológicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Talidomida / Síndromes Mielodisplásicos / Factores Inmunológicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos